HHC classified as a narcotic: the full timeline of a ban (2022-2026)

Hexahydrocannabinol is a semi-synthetic cannabinoid very close to THC, obtained in the laboratory by transforming hemp cannabinoids. It was not explicitly covered by French regulations: it is that grey area that allowed it to be sold openly — specialist shops, online retailers — for more than a year, often on the "wellness" shelf next to CBD.

The difference with CBD is nonetheless fundamental: HHC is psychotropic, its effects are close to those of THC, and no serious clinical data exist on its short- or long-term toxicity.

• 2022 – early 2023: open sale. HHC spreads across France in the wake of the CBD market, with no clear status. Reports of toxicity reach poison control centres and the ANSM.
• 12 June 2023: the decision. The ANSM classifies HHC and two of its derivatives, HHCO and HHCP, on the narcotics list. The measure takes effect on 13 June 2023: production, sale and use become prohibited in France.
• 13 June 2023: the ban takes effect. Shops have to pull the products overnight. The agency justifies its decision by a risk of abuse and dependence equivalent to that of cannabis, and by consumption occurring without users' knowledge.
• 22 May and 3 June 2024: the response to the replacements. Rather than disappearing, HHC was replaced on the shelves by analogues. The ANSM then adds new cannabinoids to the narcotics list: H4-CBD, H2-CBD, THCP, THCA, HHCPO, the entire chemical family with a benzo[c]chromene core, and several purely synthetic cannabinoids.
• 2025-2026: updates continue. The list of classified substances is updated as new replacement molecules appear on the market.

The HHC pattern reproduces, ten years on, that of Britain's Spice: a molecule legal by omission, a market that rushes in, a ban, then replacements ever further from THC and ever less documented. We tell that story — from the synthesis of JWH-018 in 1995 to sprayed flowers sold as CBD — in our article on synthetic cannabinoids and their dangers.

Since 13 June 2023, HHC has fallen under the narcotics regime: possessing it, buying it and using it are prohibited in France, on the same footing as cannabis. In practical terms:

• A product sold as "HHC" online or in a shop is illegal, whatever its presentation.
• The analogues that have appeared since (H4-CBD, THCP, HHCPO and so on) are just as illegal since June 2024.
• CBD, for its part, remains legal: cannabidiol extracted from hemp, with a THC content below 0.30%, is not affected by these classifications. Our Canna·wiki documents each cannabinoid and its French and European regulatory status.

The only reliable reflex remains the batch's HPLC certificate of analysis, which establishes a product's real cannabinoid profile. That is what we provide for every batch sold at the laboratory, on request.

Is HHC still legal anywhere in Europe?

In France, no: it has been classified as a narcotic since 13 June 2023. Status varies from one member state to another, each regulating new synthetic products at its own pace — but the European trend is towards classification.

Is HHC natural?

The HHC that was sold was produced in the laboratory, by chemically transforming cannabinoids extracted from hemp. That semi-synthetic status sets it radically apart from CBD, which is extracted directly from the plant.

What is the difference between HHC, HHCO and HHCP?

They are three molecules from the same family: HHCO and HHCP are derivatives of HHC, with reportedly stronger effects. All three were classified as narcotics together by the ANSM decision of 12 June 2023, effective 13 June 2023.